Cargando…
Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
GAD autoantibodies (GADAs) are sensitive markers of islet autoimmunity and type 1 diabetes. They form the basis of robust prediction models and are widely used for the recruitment of subjects at high risk of type 1 diabetes to prevention trials. However, GADAs are also found in many individuals at l...
Autores principales: | Williams, Alistair J.K., Lampasona, Vito, Schlosser, Michael, Mueller, Patricia W., Pittman, David L., Winter, William E., Akolkar, Beena, Wyatt, Rebecca, Brigatti, Cristina, Krause, Stephanie, Achenbach, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542444/ https://www.ncbi.nlm.nih.gov/pubmed/25972570 http://dx.doi.org/10.2337/db14-1693 |
Ejemplares similares
-
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
por: Marzinotto, Ilaria, et al.
Publicado: (2023) -
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12
por: Achenbach, Peter, et al.
Publicado: (2018) -
An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011) -
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β
por: Schlosser, Michael, et al.
Publicado: (2011) -
Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
por: McGinty, John W., et al.
Publicado: (2014)